Surmodics, Inc., a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays, has been making waves in the medical industry both in the United States and internationally. With a focus on enhancing access, deliverability, and predictable deployment of medical devices, Surmodics' Medical Device segment provides drug-delivery coating technologies for site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets. The company also manufactures vascular intervention medical devices including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. In addition to its Medical Device segment, Surmodics' In Vitro Diagnostics (IVD) segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests. This includes protein stabilizers, substrates, surface coatings, and antigens. These products are utilized in both diagnostic and biomedical research markets. Founded in 1979, Surmodics is headquartered in Eden Prairie, Minnesota, and has become a major player in the medical industry with its innovative and performance-driven solutions. With its focus on medical device and diagnostic technologies, the company is poised for continued success and growth in both domestic and international markets.